The company disclosed revenue of $13.7 billion and adjusted earnings of $0.92 per share, compared to consensus estimates of ...

Pfizer PFE shares spiked +3% in Tuesday’s trading session as the pharmaceutical giant was able to crush its Q1 earnings expectations this morning. Still, Pfizer stock has fallen 10% year to date and ...

The drugmaker reported adjusted earnings per share of 92 cents, beating expectations of 67 cents, according to analysts ...

Analysts expect the New York-based company to report quarterly earnings at 68 cents per share, down from 82 cents per share ...

Short interest in Pfizer Inc (NYSE:PFE) decreased during the last reporting ... to close out their positions without sending the stock sharply higher.

Pfizer (PFE) stock slips after the company's lower than expected Q1 2025 revenue and the firm seeks acquisitions to boost its ...

Pfizer is deeply undervalued, and has a high dividend yield, and I see tons of institutions and analysts buying the dip. Read ...

Pfizer Inc. is cutting at least another $1.2 billion from its spending while the company searches for its next big hit after ...

Pfizer maintained its 2025 guidance but noted it does not include any impact of tariffs or trade policy, “which we are unable ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

U.S. stock futures point slightly higher following mixed trading in the previous session, with a bevy of corporate earnings and economic data in focus. U.S. President Donald Trump is set to soften his ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...